跳至主要内容
临床试验/EUCTR2020-003660-11-NL
EUCTR2020-003660-11-NL进行中(未招募)1 期

Do effects of methylphenidate decline after long-term use? A double-blind, placebo-controlled cross-over study of effects of methylphenidate on cognitive functioning and real world behavior in treatment naïve children compared to effects after 9 months of treatment in clinical practice - MEDUSA

Accare0 个研究点目标入组 60 人开始时间: 2020年12月21日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Children between the ages 6 and 12, any ethnicity or cultural background
  • Who have been diagnosed with ADHD as confirmed with the Parent Interview for Child Symptoms (PICS) (obtained during routine clinical assessment)
  • Who are going to start methylphenidate as per clinical decision
  • No use of methylphenidate for the past six months
  • Have a bodyweight of at least 20 kilograms
  • Deemed reliable and compliant with the protocol
  • Parents (or the legal guardian) and children (twelve years) have provided informed consent to participate in the study.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 60
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Intellectual disability (based on available IQ below 70 or the clinical opinion of the investigator, taking into account relevant psychosocial information, e.g. educational level/academic achievements; or as confirmed by the IDS-2 IQ screener obtained in each participant, see section 7.1.2)

研究者

发起方
Accare

相似试验